Systematic Reviews
Copyright ©The Author(s) 2024.
World J Diabetes. May 15, 2024; 15(5): 1001-1010
Published online May 15, 2024. doi: 10.4239/wjd.v15.i5.1001
Table 1 Studies on acarbose to inhibit amylase in type 2 diabetes mellitus patients
Ref.
Population
Methods
Outcomes
Chen et al[8], 202317 Chinese T2DM patients, enrolled for 8 wkAcarbose (100 mg; 3 times/d) + DF-rich diet; control group: Standard dietIntervention resulted in decreased HbA1c, fasting glucose, and insulin sensitivity. No significant changes in the control group
Zhao et al[9], 201843 Chinese T2DM patients, enrolled for 11 wkAcarbose (100 mg; 3 times/d) + DF-rich diet; control group: Standard dietIntervention group showed sustained better glycemic control (HbA1c < 7%) for 89% of participants compared to the control. No significant differences in fasting glucose levels